Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Non-Current Deffered Revenue (2022 - 2025)

Core Laboratories (CLB) has 4 years of Non-Current Deffered Revenue data on record, last reported at $31.1 million in Q3 2025.

  • For Q3 2025, Non-Current Deffered Revenue fell 2.08% year-over-year to $31.1 million; the TTM value through Sep 2025 reached $31.1 million, down 2.08%, while the annual FY2024 figure was $31.1 million, 1.87% up from the prior year.
  • Non-Current Deffered Revenue reached $31.1 million in Q3 2025 per CLB's latest filing, up from $29.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $31.8 million in Q4 2022 and bottomed at $29.2 million in Q1 2025.
  • Average Non-Current Deffered Revenue over 4 years is $30.7 million, with a median of $30.7 million recorded in 2024.
  • Peak YoY movement for Non-Current Deffered Revenue: grew 1.87% in 2024, then decreased 4.11% in 2025.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $31.8 million in 2022, then decreased by 3.99% to $30.5 million in 2023, then grew by 1.87% to $31.1 million in 2024, then fell by 0.2% to $31.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $31.1 million in Q3 2025, $29.6 million in Q2 2025, and $29.2 million in Q1 2025.